nintedanib 150 MG Oral Capsule [Ofev]

RxCUI
1592752
RxNorm name
nintedanib 150 MG Oral Capsule [Ofev]
Display name
nintedanib 150 MG Oral Capsule [Ofev]
Full name
nintedanib 150 MG Oral Capsule [Ofev]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OfevNINTEDANIBBoehringer Ingelheim Pharmaceuticals, Inc.da1c9f37-779e-4682-816f-93d0faa4cfc92025-11-20Warnings, Adverse reactionsExact identifier
rxcui: 1592752

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
da1c9f37-779e-4682-816f-93d0faa4cfc9nintedanib 150 MG Oral Capsule [Ofev]SBD21These highlights do not include all the information needed to use OFEV safely and effectively. See full prescribing information for OFEV. OFEV ® (nintedanib capsules), for oral use Initial U.S. Approval: 201420251120
da1c9f37-779e-4682-816f-93d0faa4cfc9Ofev 150 MG (as nintedanib ethanesulfonate 180.6 MG) Oral CapsuleSY21These highlights do not include all the information needed to use OFEV safely and effectively. See full prescribing information for OFEV. OFEV ® (nintedanib capsules), for oral use Initial U.S. Approval: 201420251120
da1c9f37-779e-4682-816f-93d0faa4cfc9Ofev 150 MG Oral CapsulePSN21These highlights do not include all the information needed to use OFEV safely and effectively. See full prescribing information for OFEV. OFEV ® (nintedanib capsules), for oral use Initial U.S. Approval: 201420251120